Xenon as an anesthetic agent, AANA J, vol.78, pp.387-392, 2010. ,
Xenon consumption during general surgery: a retrospective observational study, Medical Gas Research, vol.3, issue.1, p.12, 2013. ,
DOI : 10.1046/j.1365-2044.2001.01715.x
Xenon Preconditioning Protects against Renal Ischemic-Reperfusion Injury via HIF-1?? Activation, Journal of the American Society of Nephrology, vol.20, issue.4, pp.713-720, 2009. ,
DOI : 10.1681/ASN.2008070712
Pretreatment With Xenon Protected Immature Rabbit Heart From Ischaemia/Reperfusion Injury by Opening of the mitoKATP Channel, Heart, Lung and Circulation, vol.22, issue.4, pp.276-283, 2013. ,
DOI : 10.1016/j.hlc.2012.10.016
Xenon and Hypothermia Combine Additively, Offering Long-Term Functional and Histopathologic Neuroprotection After Neonatal Hypoxia/Ischemia, Stroke, vol.39, issue.4, pp.1307-1313, 2008. ,
DOI : 10.1161/STROKEAHA.107.499822
Xenon augmented hypothermia reduces early lactate/N-acetylaspartate and cell death in perinatal asphyxia, Annals of Neurology, vol.15, issue.pt 8, pp.133-150, 2011. ,
DOI : 10.1002/ana.22387
Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia, Anesthesiology, vol.112, pp.614-622, 2010. ,
Reduction of Ischemic Brain Damage by Nitrous Oxide and Xenon, Journal of Cerebral Blood Flow & Metabolism, vol.23, pp.1168-1173, 2003. ,
DOI : 10.1097/01.WCB.0000087342.31689.18
Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model, Anesthesiology, vol.109, pp.782-789, 2008. ,
Cooling Combined with Immediate or Delayed Xenon Inhalation Provides Equivalent Long-Term Neuroprotection after Neonatal Hypoxia???Ischemia, Journal of Cerebral Blood Flow & Metabolism, vol.31, issue.4, pp.707-714, 2009. ,
DOI : 10.1038/jcbfm.2008.163
Morphological Evidence that Xenon Neuroprotects against N-Methyl-DL-Aspartic Acid-Induced Damage in the Rat Arcuate Nucleus: A Time-Dependent Study, Annals of the New York Academy of Sciences, vol.61, issue.1, pp.650-658, 2006. ,
DOI : 10.1196/annals.1344.025
Effects of xenon on ischemic spinal cord injury in rabbits: a comparison with propofol, Acta Anaesthesiologica Scandinavica, vol.54, issue.3, pp.337-342, 2010. ,
DOI : 10.1111/j.1399-6576.2009.02111.x
Xenon Improves Neurologic Outcome and Reduces Secondary Injury Following Trauma in an In Vivo Model of Traumatic Brain Injury*, Critical Care Medicine, vol.43, issue.1, pp.149-158, 2015. ,
DOI : 10.1097/CCM.0000000000000624
Neuroprotection against Traumatic Brain Injury by Xenon, but Not Argon, Is Mediated by Inhibition at the N-Methyl-D-Aspartate Receptor Glycine Site, Anesthesiology, vol.119, issue.5, pp.1137-1148, 2013. ,
DOI : 10.1097/ALN.0b013e3182a2a265
Argon: Systematic Review on Neuro- and Organoprotective Properties of an ???Inert??? Gas, International Journal of Molecular Sciences, vol.15, issue.10, pp.18175-18196, 2014. ,
DOI : 10.3390/ijms151018175
Ex Vivo and In Vivo Neuroprotection Induced by Argon When Given after an Excitotoxic or Ischemic Insult, PLoS ONE, vol.40, issue.2, p.30934, 2003. ,
DOI : 10.1371/journal.pone.0030934.t001
Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats*, Critical Care Medicine, vol.39, issue.6, pp.1448-1453, 2011. ,
DOI : 10.1097/CCM.0b013e31821209be
Argon Inhalation Attenuates Retinal Apoptosis after Ischemia/Reperfusion Injury in a Time- and Dose-Dependent Manner in Rats, PLoS ONE, vol.386, issue.12, p.115984, 2014. ,
DOI : 10.1371/journal.pone.0115984.g008
Neuronal Preconditioning by Inhalational Anesthetics, Anesthesiology, vol.110, issue.5, pp.986-995, 2009. ,
DOI : 10.1097/ALN.0b013e31819dadc7
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930813
Identification of Two Mutations (F758W and F758Y) in the N-methyl-D-aspartate Receptor Glycine-binding Site that Selectively Prevent Competitive Inhibition by Xenon without Affecting Glycine Binding, Anesthesiology, vol.117, issue.1, pp.38-47, 2012. ,
DOI : 10.1097/ALN.0b013e31825ada2e
Competitive Inhibition at the Glycine Site of the N-Methyl-d-aspartate Receptor by the Anesthetics Xenon and Isoflurane, Anesthesiology, vol.107, issue.5, pp.756-767, 2007. ,
DOI : 10.1097/01.anes.0000287061.77674.71
Antiapoptotic activity of argon and xenon, Cell Cycle, vol.56, issue.16, pp.2636-2642, 2013. ,
DOI : 10.1016/j.celrep.2012.06.017
URL : https://hal.archives-ouvertes.fr/hal-00919297
Neuronal and glial calcium signaling in Alzheimer???s disease, Cell Calcium, vol.34, issue.4-5, pp.385-397, 2003. ,
DOI : 10.1016/S0143-4160(03)00128-3
The potential role of kynurenines in Alzheimer???s disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors, Journal of Neural Transmission, vol.145, issue.6, pp.881-889, 2014. ,
DOI : 10.1007/s00702-013-1135-5
A?? induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss, Proceedings of the National Academy of Sciences, vol.110, issue.27, pp.2518-2527, 2013. ,
DOI : 10.1073/pnas.1306832110
Memantine for dementia, Cochrane Database Syst Rev, vol.50, issue.8, p.3154, 2006. ,
DOI : 10.1002/14651858.CD003154.pub5
Profound loss of layer II entorhinalcortex neurons occurs in very mild Alzheimer's disease, J Neurosci, vol.16, pp.4491-4500, 1996. ,
The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?, Learning & Memory, vol.11, issue.1, pp.43-49, 2004. ,
DOI : 10.1101/lm.69204
Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles, Brain, vol.136, issue.12, pp.3738-3752, 2013. ,
DOI : 10.1093/brain/awt273
NORADRENERGIC AND CHOLINERGIC SYSTEMS IN SENILE DEMENTIA OF ALZHEIMER TYPE, The Lancet, vol.318, issue.8238, p.149, 1981. ,
DOI : 10.1016/S0140-6736(81)90327-5
Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease, Neurobiology of Aging, vol.11, issue.1, pp.3-13, 1990. ,
DOI : 10.1016/0197-4580(90)90056-6
Comparison of effects of DL-threo-beta-benzyloxyaspartate (DL-TBOA) and L-trans-pyrrolidine-2,4-dicar- boxylate (t-2,4-PDC) on uptake and release of [3H]-D-aspartate in astrocytes and glutamatergic neurons, Neurochemical Research, vol.26, issue.6, pp.661-666, 2001. ,
DOI : 10.1023/A:1010939304104
Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction, Journal of Neurochemistry, vol.25, issue.2, pp.484-496, 2008. ,
DOI : 10.1159/000017342
URL : https://hal.archives-ouvertes.fr/hal-00306698
Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation, Molecular and Cellular Neuroscience, vol.40, issue.4, pp.463-473, 2009. ,
DOI : 10.1016/j.mcn.2009.01.002
URL : https://hal.archives-ouvertes.fr/hal-00409242
Mechanistic Insights into Xenon Inhibition of NMDA Receptors from MD Simulations, The Journal of Physical Chemistry B, vol.114, issue.27, pp.9010-9016, 2010. ,
DOI : 10.1021/jp101687j
Depolarization-induced release of [3H]d-aspartate from GABAergic neurons caused by reversal of glutamate transporters, International Journal of Developmental Neuroscience, vol.18, issue.2-3, pp.309-315, 2000. ,
DOI : 10.1016/S0736-5748(99)00099-4
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways, Nature Neuroscience, vol.5, pp.405-414, 2002. ,
DOI : 10.1038/nn835
Synaptic NMDA Receptor Activation Stimulates ??-Secretase Amyloid Precursor Protein Processing and Inhibits Amyloid-?? Production, Journal of Neuroscience, vol.29, issue.14, pp.4442-4460, 2009. ,
DOI : 10.1523/JNEUROSCI.6017-08.2009
Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization, Journal of Neurochemistry, vol.319, issue.4, pp.1118-1128, 2009. ,
DOI : 10.1111/j.1471-4159.2009.06040.x
The chemistry and biological activities of N-acetylcysteine, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1830, issue.8, pp.4117-4129, 2013. ,
DOI : 10.1016/j.bbagen.2013.04.016
Inhibitory actions of bilberry anthocyanidins on angiogenesis, Phytotherapy Research, vol.64, issue.S1, pp.42-47, 2010. ,
DOI : 10.1002/ptr.2895
Neuroprotective gases ??? Fantasy or reality for clinical use?, Progress in Neurobiology, vol.115, pp.210-245, 2014. ,
DOI : 10.1016/j.pneurobio.2014.01.001
Neuropathological Alterations in Alzheimer Disease, Cold Spring Harbor Perspectives in Medicine, vol.1, issue.1, p.6189, 2011. ,
DOI : 10.1101/cshperspect.a006189
Slow excitotoxicity in Alzheimer's disease, J Alzheimers Dis, vol.35, pp.643-668, 2013. ,
Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders, Neuron, vol.82, issue.2, pp.279-293, 2014. ,
DOI : 10.1016/j.neuron.2014.03.030
Neither Xenon nor Fentanyl Induces Neuroapoptosis in the Newborn Pig Brain, Anesthesiology, vol.119, issue.2, pp.345-357, 2013. ,
DOI : 10.1097/ALN.0b013e318294934d
How does xenon produce anaesthesia?, Nature, vol.396, issue.6709, p.324, 1998. ,
DOI : 10.1038/24525
Pathologically-Activated Therapeutics for Neuroprotection: Mechanism of NMDA Receptor Block by Memantine and S-Nitrosylation, Current Drug Targets, vol.8, issue.5, pp.621-632, 2007. ,
DOI : 10.2174/138945007780618472
Glycine-dependent activation of NMDA receptors, The Journal of General Physiology, vol.15, issue.6, pp.513-527, 2015. ,
DOI : 10.1007/BF00711446
The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats*, Critical Care Medicine, vol.40, issue.6, pp.1724-1730, 2012. ,
DOI : 10.1097/CCM.0b013e3182452164
Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine, Journal of Neuroscience, vol.29, issue.9, pp.2774-2779, 2009. ,
DOI : 10.1523/JNEUROSCI.3703-08.2009
Oxidative stress, glutamate, and neurodegenerative disorders, Science, vol.262, issue.5134, pp.689-695, 1993. ,
DOI : 10.1126/science.7901908
NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation, Nature Neuroscience, vol.169, issue.7, pp.857-863, 2009. ,
DOI : 10.1097/00004647-200002000-00018
NMDA Receptor Activation Increases Free Radical Production through Nitric Oxide and NOX2, Journal of Neuroscience, vol.29, issue.8, pp.2545-2552, 2009. ,
DOI : 10.1523/JNEUROSCI.0133-09.2009
Nitric Oxide, Annals of the New York Academy of Sciences, vol.34, issue.1, pp.389-401, 2002. ,
DOI : 10.1111/j.1749-6632.2002.tb04083.x
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals, Nature Medicine, vol.81, issue.6, pp.688-694, 2007. ,
DOI : 10.1038/nm1577
Hydrogen Sulfide Increases Glutathione Production and Suppresses Oxidative Stress in Mitochondria, Antioxidants & Redox Signaling, vol.12, issue.1, pp.1-13, 2010. ,
DOI : 10.1089/ars.2008.2282
Regulation of Cholinergic Phenotype in Developing Neurons, Journal of Neurophysiology, vol.99, issue.5, pp.2443-2455, 2008. ,
DOI : 10.1152/jn.00762.2007
Non-Cell-Autonomous Mechanism of Activity-Dependent Neurotransmitter Switching, Neuron, vol.82, issue.5, pp.1004-1016, 2014. ,
DOI : 10.1016/j.neuron.2014.04.029
Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymes, J Neurosci, vol.8, pp.2967-2985, 1988. ,
Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study., Proceedings of the National Academy of Sciences, vol.89, issue.20, pp.9549-9553, 1992. ,
DOI : 10.1073/pnas.89.20.9549
Cholinergic system during the progression of Alzheimer???s disease: therapeutic implications, Expert Review of Neurotherapeutics, vol.8, issue.11, pp.1703-1718, 2008. ,
DOI : 10.1586/14737175.8.11.1703
Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+, The FASEB Journal, vol.25, issue.8, pp.2563-2573, 2011. ,
DOI : 10.1096/fj.11-182824
The Neurotransmitter Noradrenaline Rescues Septal Cholinergic Neurons in Culture from Degeneration Caused by Low-Level Oxidative Stress, Molecular Pharmacology, vol.67, issue.6, pp.1882-1891, 2005. ,
DOI : 10.1124/mol.104.007864
Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K+ requires concurrent inactivation of NMDA or AMPA/kainate receptors, Journal of Neurochemistry, vol.67, issue.1, pp.163-174, 2001. ,
DOI : 10.1046/j.1471-4159.2001.00401.x
The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license ,